Revolutionary CAR-T shot? new therapy builds cancer fighters inside you
NCT ID NCT07485504
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new treatment called DIT101 for people with blood cancers that have come back or stopped responding to other treatments. DIT101 is given as an IV infusion and works by creating cancer-fighting cells inside the body, avoiding the need to remove and modify cells in a lab. The study will enroll 15 adults to check safety and see if the therapy can shrink tumors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hematology Hospital of Chinese Academy of Medical Sciences (Hematology Research Center of Chinese Academy of Medical Sciences)
Tianjin, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.